Northern Trust’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Northern Trust’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-161,975	Closed	-$10.1M	–	4525
2023 Q4	$10.1M	Buy	+161,975	New	+$4.03M	﹤0.01%	2063

Northern Trust's RYZB Position: Q1 2024 in Review

Northern Trust sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 161,975 shares — an estimated $10.1M sold.

Northern Trust first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $10.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Northern Trust reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Northern Trust sold 161,975 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $10.1M.
Northern Trust first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Northern Trust's RayzeBio, Inc. Common Stock position peaked at $10.1M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.